## **Core Concept**
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive type of non-Hodgkin lymphoma that is confined to the central nervous system (CNS), including the brain, eyes, spinal cord, and meninges. It is a type of extranodal lymphoma. PCNSL typically affects immunocompromised individuals, such as those with HIV/AIDS, but it can also occur in immunocompetent individuals.

## **Why the Correct Answer is Right**
The correct answer is related to the characteristic features of PCNSL. One key feature is that PCNSL is often associated with **Epstein-Barr Virus (EBV)**, particularly in immunocompromised patients. Another important aspect is that PCNSLs are typically **monoclonal B-cell lymphomas**. They have a high tendency to involve **the cerebral hemispheres**, and they often present with **symptoms related to increased intracranial pressure** or focal neurological deficits.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific details of option A, we cannot directly address its inaccuracies. However, common incorrect statements might include claims that PCNSL is more common in immunocompetent individuals than in immunocompromised ones or that it frequently presents with systemic symptoms early on.
- **Option B:** Similarly, without specifics, we can't directly refute, but generally, incorrect options might suggest features more typical of other CNS pathologies, such as metastatic brain tumors or gliomas.
- **Option C:** This option could potentially be incorrect if it suggests a common feature not typically associated with PCNSL, such as a high rate of cure with simple antibiotics or a predilection for certain age groups without acknowledging the immunocompromised status.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for PCNSL is that it **often presents with a ring or homogeneous enhancement pattern on MRI with gadolinium**, and there's a high association with **EBV in immunocompromised patients**. Early diagnosis and treatment, which may include chemotherapy (such as high-dose methotrexate-based regimens) and/or radiation therapy, are critical for improving outcomes.

## **Correct Answer:** D.